Federal regulations

The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.

The U.S. Customs and Border Protection requests public comment on a revised information collection form for duty-free entry of scientific instruments and apparatus; comments due 30 days from Federal Register publication.

FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.

FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.

FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.

NMFS closes the Atlantic bluefin tuna angling category trophy fishery in Southern New England for 2026 for fish measuring 73 inches or greater curved fork length.

U.S. Department of Commerce finds that Mexican carbon and alloy steel wire rod producers made sales below normal value during the October 1, 2023 through September 30, 2024 review period.

The U.S. Department of Commerce is investigating whether corrosion-resistant steel products from China completed in Thailand circumvent existing antidumping and countervailing duty orders.

The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.

I need the description to create an accurate summary. Please provide the description field for this OMB submission document.